298 related articles for article (PubMed ID: 24291618)
21. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
[TBL] [Abstract][Full Text] [Related]
22. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
[TBL] [Abstract][Full Text] [Related]
23. The risk of chronic kidney disease in tuberculosis: a population-based cohort study.
Shen TC; Huang KY; Chao CH; Wang YC; Muo CH; Wei CC; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC; Kao CH
QJM; 2015 May; 108(5):397-403. PubMed ID: 25352683
[TBL] [Abstract][Full Text] [Related]
24. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
[TBL] [Abstract][Full Text] [Related]
25. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
26. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
27. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
28. [Proton pump inhibitors and kidney].
Desbuissons G; Deray G; Mercadal L
Nephrol Ther; 2018 Apr; 14 Suppl 1():S115-S124. PubMed ID: 29274872
[TBL] [Abstract][Full Text] [Related]
29. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
[TBL] [Abstract][Full Text] [Related]
30. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.
Meijvis SC; Cornips MC; Voorn GP; Souverein PC; Endeman H; Biesma DH; Leufkens HG; van de Garde EM
Eur Respir J; 2011 Nov; 38(5):1165-72. PubMed ID: 21478217
[TBL] [Abstract][Full Text] [Related]
31. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
[TBL] [Abstract][Full Text] [Related]
32. Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia.
Hung TH; Tseng CW; Tsai CC; Lee HF
PLoS One; 2019; 14(4):e0216041. PubMed ID: 31022265
[TBL] [Abstract][Full Text] [Related]
33. Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study.
Hung SK; Chen YC; Chiou WY; Lai CL; Lee MS; Lo YC; Chen LC; Huang LW; Chien NC; Li SC; Liu DW; Hsu FC; Tsai SJ; Chan MW; Lin HY
BMJ Open; 2017 Sep; 7(9):e015022. PubMed ID: 28963281
[TBL] [Abstract][Full Text] [Related]
34. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
35. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
36. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study.
Ramírez E; Cabañas R; Laserna LS; Fiandor A; Tong H; Prior N; Calderón O; Medrano N; Bobolea I; Frías J; Quirce S
Clin Exp Allergy; 2013 Mar; 43(3):344-52. PubMed ID: 23414543
[TBL] [Abstract][Full Text] [Related]
38. Acid-suppressive drugs and community-acquired pneumonia.
Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
[TBL] [Abstract][Full Text] [Related]
39. PPIs and kidney disease: from AIN to CKD.
Moledina DG; Perazella MA
J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
[TBL] [Abstract][Full Text] [Related]
40. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
